# Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients

> **NCT02731612** · PHASE3 · COMPLETED · sponsor: **Lakshmi N Yatham** · enrollment: 100 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** lurasidone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02731612
- **Lead sponsor:** Lakshmi N Yatham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-08
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02731612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02731612, "Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02731612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*